Acute promyelocytic leukemia epidemiology and demographics

Acute promyelocytic leukemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Acute promyelocytic leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Imaging Studies
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary PreventionSurgery
Secondary PreventionSurgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Acute promyelocytic leukemia epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Acute promyelocytic leukemia epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Acute promyelocytic leukemia epidemiology and demographics
CDC on Acute promyelocytic leukemia epidemiology and demographics
Acute promyelocytic leukemia epidemiology and demographics in the news
Blogs on Acute promyelocytic leukemia epidemiology and demographics
Directions to Hospitals Treating Acute promyelocytic leukemia
Risk calculators and risk factors for Acute promyelocytic leukemia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Epidemiology and Demographics

Acute promyelocytic leukemia represents 5-8% of AML in adults. The median age is approximately 40 years, which is considerably younger than the other subtypes of AML (70 years). The incidence is increased in patients originated in Latin American countries.(Douer et al.)